A new report from DelveInsight on the sleep apnea diagnostic devices market takes a dive into the sleep apnea diagnostic devices market drivers, barriers, and trends, and key sleep apnea diagnostic devices companies.

Key Takeaways from the Sleep Apnea Diagnostic Devices Market Report

  • As per DelveInsight estimates, North America is anticipated to dominate the global sleep apnea diagnostic devices market during the forecast period. 
  • Key sleep apnea diagnostic devices companies such as Natus Medical Incorporated., SOMNOmedicsGmbH, Compumedics Limited, ZOLL Itamar Ltd., Nihon Kohden Corporation, Vyaire., Cleveland Medical Devices Inc., Cadwell Industries Inc., Koninklijke Philips N.V., InMode Aesthetic Solutions, ResMed, Resonea, DeVilbiss Healthcare LLC, Smiths Group Plc. (Smiths Medical), Hemodiaz Life Sciences Private Limited., ActiGraph, LLC., Advin Health Care, Recorders & Medicare Systems Pvt Ltd (RMS), Allengers, EB Neuro S.p.A., and several others are currently dominating the sleep apnea diagnostic devices market. 
  • In November 2022, Philips Respironics provided an update on MDRs submitted in connection with the voluntary recall notification and field safety notice for specific ASX-listed CPAP, BiPAP, and mechanical ventilator devices. ResApp Health has received 510(k) clearance from the US Food and Drug Administration for SleepCheckRx, its mobile sleep apnea screening app.
  • In October 2022, Acurable raised €11 million to expand its at-home sleep apnea testing device globally.
  • In May 2022, RemSleep Holdings Inc, a medical device manufacturer dedicated to permanently changing the level of treatment provided to obstructive sleep apnea patients, announced that the company has responded to the Additional Information request pertaining to their current 510(k) application to the United States Food and Drug Administration (FDA) for its patented DeltaWave device, a nasal mask CPAP interface.
  • In November 2021, Acurable, UK medical device firm has earned FDA 510(k) clearance for its AcuPebble SA100 home sleep apnea testing device. The small, wearable device provides automated, remote home testing for obstructive sleep apnea (OSA).
  • In September 2021, Asahi Kasei unit ZOLL Medical entered a definitive agreement to acquire medical device and digital health company Itamar Medical for nearly $538m.
  • In June 2021, Somnoware, one of the players in digital sleep and respiratory health management, announced its collaboration with Itamar Medical, another leading Israeli sleep apnea company. The company announced the integration of the WatchPAT One device with its Sleep Device Interface (SDI) that provides manufacturer independent, browser-based interface for diagnostic device operations.